{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-001061","form_type":"8-K","ticker":"UFPT","cik":"0000914156","company_name":"UFP TECHNOLOGIES INC","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.784556+00:00","generated_at":"2026-05-26T05:20:12.448666+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"UFP Technologies reports record 2024 revenue of $504.4M, adj. EPS $8.68, up 31%","bullets":["Full-year net income $59.0M (+31.3%); adjusted net income $67.6M (+32.5%); GAAP EPS $7.58, adj. EPS $8.68.","Q4 sales $144.1M (+41.9%); Q4 adj. net income $19.2M (+51.6%); Q4 adj. EPS $2.46.","MedTech sales grew 48.6% in Q4 and 30.2% for full year; gross margin improved to 29.1% from 28.1%.","Adjusted EBITDA for 2024 reached $107.3M, up 39.1% from $77.2M in 2023.","CEO cites acquisitions performing ahead, Dominican Republic expansion, and two major programs launching H2 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-001061","json":"https://secwatch.observer/filing/0001171843-25-001061.json","markdown":"https://secwatch.observer/filing/0001171843-25-001061.md","text":"https://secwatch.observer/filing/0001171843-25-001061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/914156/000117184325001061/0001171843-25-001061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/914156/000117184325001061/f8k_022525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:20:12.448666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}